[Benign prostatic hyperplasia: treatment options in the dog].
Benign prostatic hyperplasia is a primarily non-inflammatory enlargement of the prostate due to proliferation of its epithelial and mesenchymal structures. These physiological alterations can be found in more than 95 % of aged intact male dogs, but common clinical symptoms as serosanguineous urethral discharge, haematuria, flattened faeces, constipation and tenesmus are only present in a few of them. In addition to surgical castration, hormonal suppression of testicular function with GnRH-depot-analogues, inhibition of the 5alpha-reductase or peripheral androgen action with anti-androgens are available today. This enables the clinician to find the optimal therapeutic strategy for each patient.
Renggli
M
M
Klinik für Fortpflanzungsmedizin der Universität Zürich.
Padrutt
I
I
Michel
E
E
Reichler
I
I
D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D002455:Cell Division; D003241:Consanguinity; D004283:Dog Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000473:pathology / Q000503:physiopathology*; D004285:Dogs; D015994:Incidence; D008297:Male; D009919:Orchiectomy; D011470:Prostatic Hyperplasia / Q000453:epidemiology / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D014463:Ultrasonography; D014965:X-Rays
D000726:Androgen Antagonists